Clinical Report: Association of Lipid and Glucose Variability with Depression in T2D
Overview
This study investigates the relationship between lipid and glucose variability and major depressive disorder (MDD) in elderly patients with type 2 diabetes (T2D). It finds that abnormal lipid levels and glucose fluctuations are significantly associated with MDD, with specific markers such as ApoB, SDBG, and LBGI identified as potential clinical indicators.
Background
Major depressive disorder (MDD) is prevalent among elderly individuals with type 2 diabetes (T2D), leading to increased morbidity and mortality. Understanding the interplay between metabolic factors like lipid levels and glycemic variability is crucial for identifying at-risk patients and improving management strategies. This study addresses a gap in research regarding these associations in older adults with T2D.
Data Highlights
Parameter
Odds Ratio (OR)
95% Confidence Interval (CI)
p-value
ApoB
15.311
2.688, 1on
0.002
SDBG
1.409
1.121, 1on
0.003
LBGI
1.327
1.101, 1on
0.003
Key Findings
The prevalence of comorbid MDD among hospitalized older adults with T2D was 59.31%.
ApoB, SDBG, and LBGI were independently associated with MDD in this population.
Significant correlations were found between glycemic variability, lipid parameters, and psychological measures.
Identifying metabolic markers can aid in the clinical management of depression in older T2D patients.
Further research is needed to confirm these findings in larger prospective studies.
Clinical Implications
Clinicians should consider monitoring lipid profiles and glycemic variability in elderly patients with T2D to identify those at risk for MDD. The identified markers may help in early detection and intervention strategies for managing depression in this vulnerable population.
Conclusion
The study highlights the strong association between lipid and glucose variability and MDD in older adults with T2D, suggesting that these metabolic factors could serve as important clinical markers.
